A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy

Status:
Completed

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Oral Mucositis associated with adjuvant radiation and concurrent chemotherapy in postoperative Head and Neck setting

Phase 1/Phase 2

Swedish Orphan Biovitrum

Amgen

Cisplatin